Overview

Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)

Status:
NOT_YET_RECRUITING

Trial end date:
2028-02-29

Target enrollment:

Participant gender:

Summary

The goal of this multicenter, double-blind, 22 factorial randomized controlled trial is to evaluate the efficacy and safety of isosorbide mononitrate, butylphthalide, and their combination in reducing disability in patients with acute lacunar stroke.

Phase:

PHASE3

Details

Lead Sponsor:

Beijing Tiantan Hospital

Collaborator:

Shenzhen Second People's Hospital

Treatments:

3-n-butylphthalide
isosorbide-5-mononitrate